Comparative evaluation between Geenius™ dual-path migration immunochromatography platform and Western blot HIV-1 for confirmatory assays in the Brazilian population
{"title":"Comparative evaluation between Geenius™ dual-path migration immunochromatography platform and Western blot HIV-1 for confirmatory assays in the Brazilian population","authors":"Rubia Heloisa Vanderlinde, Graziele Cristina Ferreira, Jussimara Monteiro Nurmberger, Daniela Calciolari Marques, Flavia Maria Correa Cristaldi, Renata Chiavarini, Debora Ribeiro Ramadan, Sergio Tufik, Carolina Xavier Lima Piccinini, Mariana do Nascimento Viana","doi":"10.1016/j.jchromb.2025.124885","DOIUrl":null,"url":null,"abstract":"<div><div>Human immunodeficiency virus (HIV) diagnosis requires both screening and confirmatory assays to accurately differentiate antigen and antibody reactivity. The Western blot (WB) method has long been considered the gold standard for confirming HIV infection. However, due to its labor-intensive workflow and technical complexity, the WB has become challenging for many clinical laboratories. Therefore, newer diagnostic techniques, such as the Dual-Path Platform (DPP) lateral flow immunochromatography assays, have been developed and approved by regulatory agencies. Automated interpretation of DPP enhances analytical sensitivity by minimizing subjectivity and allowing detection of faint bands, reducing the probability of false-negative results. This study compared the performance of the WB and DPP as confirmatory methods following chemiluminescent immunoassay (CLIA) screening. All samples were previously screened using CLIA and subsequently analyzed by both WB and DPP assays. Samples yielding borderline CLIA results underwent additional testing by RT-qPCR. The DPP platform demonstrated high concordance with the WB assay, achieving an agreement rate of 97.2 % and a kappa index of 93.9 %, indicating excellent predictive performance. Borderline results were confirmed as reactive by both DPP and RT-qPCR but remained indeterminate by WB. Although complete agreement between both confirmatory methods was not achieved, no clinically significant discrepancies were observed, suggesting that such variations did not impact patient outcomes. Despite the WB remaining as a reference confirmatory method for HIV diagnosis, the DPP method offers substantial advantages, including shorter turnaround time, greater operational simplicity, and automated digital documentation, making it a practical alternative for routine use in high-throughput or resource-limited laboratory settings.</div></div>","PeriodicalId":348,"journal":{"name":"Journal of Chromatography B","volume":"1269 ","pages":"Article 124885"},"PeriodicalIF":2.5000,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chromatography B","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570023225004398","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Human immunodeficiency virus (HIV) diagnosis requires both screening and confirmatory assays to accurately differentiate antigen and antibody reactivity. The Western blot (WB) method has long been considered the gold standard for confirming HIV infection. However, due to its labor-intensive workflow and technical complexity, the WB has become challenging for many clinical laboratories. Therefore, newer diagnostic techniques, such as the Dual-Path Platform (DPP) lateral flow immunochromatography assays, have been developed and approved by regulatory agencies. Automated interpretation of DPP enhances analytical sensitivity by minimizing subjectivity and allowing detection of faint bands, reducing the probability of false-negative results. This study compared the performance of the WB and DPP as confirmatory methods following chemiluminescent immunoassay (CLIA) screening. All samples were previously screened using CLIA and subsequently analyzed by both WB and DPP assays. Samples yielding borderline CLIA results underwent additional testing by RT-qPCR. The DPP platform demonstrated high concordance with the WB assay, achieving an agreement rate of 97.2 % and a kappa index of 93.9 %, indicating excellent predictive performance. Borderline results were confirmed as reactive by both DPP and RT-qPCR but remained indeterminate by WB. Although complete agreement between both confirmatory methods was not achieved, no clinically significant discrepancies were observed, suggesting that such variations did not impact patient outcomes. Despite the WB remaining as a reference confirmatory method for HIV diagnosis, the DPP method offers substantial advantages, including shorter turnaround time, greater operational simplicity, and automated digital documentation, making it a practical alternative for routine use in high-throughput or resource-limited laboratory settings.
Geenius™双路迁移免疫层析平台和Western blot HIV-1在巴西人群验证性检测中的比较评价
人类免疫缺陷病毒(HIV)的诊断需要筛查和确认试验来准确区分抗原和抗体的反应性。长期以来,Western blot (WB)方法一直被认为是确认HIV感染的金标准。然而,由于其劳动密集型工作流程和技术复杂性,WB已成为许多临床实验室的挑战。因此,新的诊断技术,如双路径平台(DPP)横向流动免疫层析分析,已经开发并得到监管机构的批准。DPP的自动解释通过最大限度地减少主观性和允许检测微弱波段来提高分析灵敏度,减少假阴性结果的可能性。本研究比较了WB和DPP作为化学发光免疫测定(CLIA)筛选后的验证性方法的性能。所有样品先前使用CLIA筛选,随后使用WB和DPP分析。获得CLIA临界结果的样品通过RT-qPCR进行了额外的检测。DPP平台与WB法具有较高的一致性,一致性率为97.2%,kappa指数为93.9%,具有良好的预测性能。DPP和RT-qPCR均证实边缘性结果具有反应性,但WB仍不确定。虽然两种验证性方法之间没有完全一致,但没有观察到临床上显著的差异,这表明这些差异不会影响患者的预后。尽管WB仍然是HIV诊断的参考验证方法,但DPP方法具有实质性优势,包括周转时间更短,操作更简单,自动化数字文档,使其成为高通量或资源有限的实验室环境中常规使用的实用替代方案。
期刊介绍:
The Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.
Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches.
Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance.